Overview
- Provides valuable and detailed insight into many of the latest techniques
- Describes several techniques, which broaden the range and improve the sensitivity and relevance of toxicity endpoints, investigated both in vitro and in vivo
- Introduces new methods and systems
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 745)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Editors and Affiliations
About the editors
MICHAEL BALLS read Zoology at Oxford University, and, after postgraduate studies in Switzerland and postdoctoral research in the USA, returned to Britain in 1966, to become a Lecturer in the School of Biological Sciences at the University of East Anglia. In 1975, he moved to the University of Nottingham Medical School, as a Senior Lecturer, and was later promoted to Reader in Medical Cell Biology and then to Professor of Medical Cell Biology. He is now an Emeritus Professor of the University. Professor Balls became a Trustee of FRAME (Fund for the Replacement of Animals in Medical Experiments) in 1979, and has been Chairman of the Trustees since 1981. He has been Editor of ATLA (Alternatives to Laboratory Animals) since 1983. He acted as an adviser to the British Government during the drafting and passage through Parliament of the Animals (Scientific Procedures) Act 1986, and, from 1987-1995, was a founder member of the Animal Procedures Committee, which advises the Government on all matters related to animal experimentation. In 1993, Professor Balls became the first Head of the European Centre for the Validation of Alternative Methods (ECVAM), which is part of the Institute for Health & Consumer Protection of the European Commission’s Joint Research Centre, located in Ispra, Italy. ECVAM is responsible for leading and coordinating efforts at the European Union level, which are aimed at reducing, refining and replacing the use of laboratory animal procedures in research, education and testing, through the development and validation of advanced testing methods. He retired from ECVAM at the end of June 2002, but continues to devote much of his time to FRAME.
ROBERT D. COMBES is an independent consultant in toxicology. He has held positions inacademia and industry, where he broadened his interests to cover in vitro toxicology, biotransformation, in silico prediction, and the Three Rs (reduction, refinement and replacement) as applied to laboratory animal experimentation. He was Scientific Director, then Director, of FRAME (Fund for the Replacement of Animals in Medical Experiments) from 1994 to 2008. He has published numerous papers, book chapters and conference proceedings, and has served on many national and international committees. He is a Fellow of the Society of Biology in the UK, has been on the editorial board of several international journals, the secretary of the United Kingdom Environmental Mutagen Society (UKEMS) and the president of the European Society of Toxicology In Vitro (ESTIV), and is now an honorary member of ESTIV.
NIRMALA BHOGAL has a first degree in Biochemistry and Pharmacology, and a PhD in Biochemistry and Molecular Biology from Leeds University, where she was a research fellow from 1991 to 2004 and specialised in rational drug design and protein chemistry. She also obtained a Postgraduate Diploma in Law from Leeds Metropolitan University. She joined FRA ME (Fund for the Replacement of Animals in Medical Experiments) in 2004, and was the Charity’s Scientific Director. Her work focused on the use of human volunteers and the application of biotechnology in the development of alternatives to the use of animal in biomedical research, and in particular, in the discovery, development and delivery of therapeutics. Since leaving FRAME in 2010, Dr Bhogal has established a legal–scientific consultancy.
Bibliographic Information
Book Title: New Technologies for Toxicity Testing
Editors: Michael Balls, Robert D. Combes, Nirmala Bhogal
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-1-4614-3055-1
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2012
Hardcover ISBN: 978-1-4614-3054-4Published: 14 February 2012
Softcover ISBN: 978-1-4939-4419-4Published: 23 August 2016
eBook ISBN: 978-1-4614-3055-1Published: 22 March 2012
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: XXVIII, 258